Navigate FDA with Confidence
From first IND to post-approval commitments, our regulatory team brings deep FDA experience to every stage of your program — so you can move faster and avoid costly missteps.
Schedule a ConsultationFull-Spectrum Regulatory Support
Regulatory strategy is not a one-time deliverable — it is a continuous discipline that shapes every decision in your development program. We embed with your team to provide the strategic guidance, submission expertise, and FDA relationship management that turns complex regulatory landscapes into clear, executable paths forward.
Regulatory Capabilities
IND Preparation & Submission
We manage the full IND package — from pre-IND meeting strategy through CMC, pharmacology/toxicology, and clinical protocol sections. Our team ensures your IND is complete, compliant, and positioned to avoid clinical holds.
- Pre-IND meeting preparation and FDA briefing documents
- CMC section development and review
- Pharmacology and toxicology summary writing
- Phase I protocol design and submission
- IND amendment management and annual reporting
NDA & BLA Strategy and Submission
Marketing application submissions require meticulous planning and flawless execution. We lead NDA and BLA preparation from rolling submission strategy through final package assembly, ensuring your data tells a compelling and complete regulatory story.
- Integrated Summary of Safety and Efficacy (ISS/ISE)
- Rolling submission planning and management
- Module 2 clinical and nonclinical summaries
- FDA advisory committee preparation
- Complete Response Letter (CRL) response strategy
FDA Meeting Strategy & Preparation
FDA meetings — Type A, B, and C — are high-stakes interactions that can define your program's trajectory. We prepare your team with rigorous briefing documents, anticipated FDA questions, and rehearsed responses that maximize meeting outcomes.
- Meeting request strategy and timing
- Briefing document writing and review
- Question formulation and prioritization
- Mock meeting preparation and coaching
- Meeting minutes review and follow-up action planning
Regulatory Pathway Analysis
Choosing the right regulatory pathway early can save years of development time. We conduct rigorous pathway analyses — evaluating standard review, priority review, accelerated approval, Breakthrough Therapy, and Fast Track designations — to identify the fastest, most defensible route to approval.
- Breakthrough Therapy Designation strategy and application
- Fast Track and Priority Review eligibility assessment
- Accelerated Approval pathway evaluation
- Orphan Drug Designation applications
- 505(b)(2) and hybrid application strategy
CMC Regulatory Support
Chemistry, Manufacturing, and Controls (CMC) issues are among the most common causes of regulatory delay. Our CMC regulatory specialists work alongside your manufacturing team to ensure your CMC package meets FDA expectations at every stage.
- CMC regulatory strategy for biologics, small molecules, and combination products
- Drug Master File (DMF) preparation and management
- Process validation regulatory support
- Post-approval CMC change management
- Comparability protocol development
Post-Approval Regulatory Management
Approval is not the finish line — it is the beginning of an ongoing regulatory relationship with FDA. We manage your post-approval obligations, labeling updates, and lifecycle strategy to protect your approval and maximize your product's commercial potential.
- Post-marketing commitment tracking and reporting
- Labeling updates and supplemental applications
- REMS development and management
- Annual report preparation
- Regulatory intelligence and competitive landscape monitoring
How We Work
A structured engagement model built for speed and transparency.
Program Assessment
We begin with a deep-dive review of your current regulatory status, data package, and development timeline to identify gaps and opportunities.
Strategy Development
We build a tailored regulatory roadmap — submission timelines, FDA interaction strategy, and risk mitigation plans — aligned to your program goals.
Execution & Oversight
Our team manages submission preparation, FDA communications, and cross-functional coordination to keep your program on track.
Continuous Guidance
We stay embedded through FDA review, responding to information requests and preparing your team for every regulatory milestone.
Ready to Build Your Regulatory Strategy?
Whether you're filing your first IND or navigating a complex resubmission, our regulatory team is ready to help. Let's talk about your program.
Schedule a Consultation